Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion type Assertion NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_head.
- NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion description "[The negative effects of cyclin G2 on cell cycle and cell proliferation, which occur without altering p27(Kip1) levels, may contribute to the ability of trastuzumab to inhibit breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_provenance.
- NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion evidence source_evidence_literature NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_provenance.
- NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion SIO_000772 18025271 NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_provenance.
- NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion wasDerivedFrom befree-20140225 NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_provenance.
- NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_assertion wasGeneratedBy ECO_0000203 NP873950.RAoGXFgirPCb-4DW2ftx2Tc2XlK9odlO5w4uM_Y1YC9YM130_provenance.